SEP 27, 2021 3:00 AM PDT

Inflammation Promotes Pancreatic Cancer Progression

WRITTEN BY: Katie Kokolus

Inflammation occurs when the immune response, including immune cells and mediators they produce, protect you from dangerous pathogens like viruses and bacteria.  In addition to attacking foreign invaders, many conditions, such as arthritis, asthma, and diabetes, are linked to inflammation.

The association between cancer and inflammation was documented as early as 1863 when Rudolf Virchow found white blood cells, also known as leukocytes, infiltrating neoplastic tissue.  Today, while the relationship between cancer and inflammation is more fully understood, researchers are actively exploring specific biological mechanisms involved.  

A study recently published in Science clarifies some of the mechanisms underlying inflammation-associated pancreatic cancer.  The research team investigated the impact of inflammation on the cells lining the pancreas, known as pancreatic epithelial cells.

Researchers induced inflammation in a mouse model of pancreatic ductal adenocarcinoma (PDAC).  Inflammatory cells infiltrated and proliferated in the pancreatic tissue following induction of inflammation.  Without further intervention, the inflammation began to resolve within a week and the immune cell profile returned to pre-induction levels in less than a month.   

The study also explored the effect of inflammation on KRAS-driven pancreatic cancer, which is representative of 95% of PDACs. Following activation of KRAS in the murine system, mice exposed to inflammation experienced accelerated tumor growth and succumbed to disease, while control mice were largely unaffected.  

Surprisingly, even when KRAS was activated three months following the inflammatory event, the tumors in mice exposed to inflammation progressed significantly faster than in control mice.  These findings suggest that inflammation imposes long-lasting alterations in pancreatic epithelial cells.  Further, when in the presence of mutant KRAS, these reprogrammed cells promote cancer progression.

Following inflammation, extensive molecular analysis of pancreatic epithelial cells demonstrated considerable modifications in gene expression.  Many of the genes activated post-inflammation, including those associated with cell survival and proliferation, have well-established roles in tumor development. The authors describe the genetic alterations that were still evident long after the inflammation resolved as epithelial memory.   

The study solidifies specific mechanisms involved in inflammation-associated pancreatic cancer.  As pancreatic cancer has one of the lowest five-year survival rates among all cancer sites, these findings are valuable to researchers as they continue to seek life-saving treatments for pancreatic cancer.

 

Sources: Inflammation1863leukocytesneoplasticScience95%five year survival

About the Author
PhD
PhD in Tumor Immunology. I am interested in developing novel strategies to improve the efficacy of immunotherapies used to extend cancer survivorship.
You May Also Like
OCT 17, 2022
Cancer
The Value of Colonoscopy Screening
OCT 17, 2022
The Value of Colonoscopy Screening
Colorectal cancer (CRC) remains the third most common type of cancer diagnosed in men and women in the United States.&nb ...
OCT 21, 2022
Drug Discovery & Development
Gel-encased Radioactive Iodine Eliminates Pancreatic Cancer in Mice
OCT 21, 2022
Gel-encased Radioactive Iodine Eliminates Pancreatic Cancer in Mice
Researchers have developed a radioactive gel that eliminated pancreatic tumors in 80% of mice. The corresponding study w ...
NOV 11, 2022
Cancer
Veterans and Burn Pit Exposure
NOV 11, 2022
Veterans and Burn Pit Exposure
Today we recognize the Veterans Day holiday in the United States.  Each year, on November 11, Americans commemorate ...
NOV 17, 2022
Cancer
Anti-Aging Supplement Linked to Aggressive Breast Cancer
NOV 17, 2022
Anti-Aging Supplement Linked to Aggressive Breast Cancer
Vitamin B3, also known as niacin, is a generic name for a group of biochemical compounds, including nicotinamide ribosid ...
NOV 28, 2022
Clinical & Molecular DX
Study Indicates that Breast Cancer Recurrence Could be Predicted Using a MicroRNA Biomarker
NOV 28, 2022
Study Indicates that Breast Cancer Recurrence Could be Predicted Using a MicroRNA Biomarker
MicroRNAs are small (between just 21 and 23 nucleotides), non-coding RNA molecules. They are involved in the post-transc ...
NOV 29, 2022
Cancer
Some Pediatric Cancer Survivors Experience Premature Aging
NOV 29, 2022
Some Pediatric Cancer Survivors Experience Premature Aging
Aging occurs when molecular damage accumulates in cells and tissues throughout the body resulting in dysfunction and dys ...
Loading Comments...